The COVID-19 crisis has put the resilience and agility of European health systems to the test in an unprecedented way, and has reminded us about the crucial importance of health and wellbeing for our societies.
As we continue to rally together in the fight against COVID-19, we also need to collectively reflect on what this crisis has taught us so far, about the state of European health systems and European health collaboration, and what could be done better or differently in the future.
EFPIA believes that once we emerge from this crisis, we should not only rebuild our economies and get our societies back on their feet (...)
Read more
The writer is Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.